| Name | (13aS)-2,3,9-Trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2 -a]isoquinolin-10-ol | 
|---|---|
| Synonyms | 6H-Dibenzo[a,g]quinolizin-10-ol, 5,8,13,13a-tetrahydro-2,3,9-trimethoxy-, (13aS)- 6H-Dibenzo(a,g)quinolizin-10-ol, 5,8,13,13a-tetrahydro-2,3,9-trimethoxy-, (S)- (13aS)-2,3,9-Trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-10-ol | 
| Description | Corydalmine (L-Corydalmine), an alkaloid isolated from roots of Corydalis Chaerophylla, inhibits spore germination of some plant pathogenic as well as saprophytic fungi[1]. Corydalmine acts as an oral analgesic agent, exhibiting potent analgesic activity[2]. Corydalmine alleviates Vincristine-induced neuropathic pain in mice by inhibiting an NF-κB-dependent CXCL1/CXCR2 signaling pathway[3]. | 
|---|---|
| Related Catalog | |
| Target | CXCR2 | 
| In Vivo | Corydalmine (L-Corydalmine) is a potent analgesic agent, in cynomolgus monkey, beagle dog, rat and mouse liver microsomes[2]. | 
| References | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 501.2±50.0 °C at 760 mmHg | 
| Melting Point | 177-178℃ | 
| Molecular Formula | C20H23NO4 | 
| Molecular Weight | 341.401 | 
| Flash Point | 256.9±30.1 °C | 
| Exact Mass | 341.162720 | 
| PSA | 51.16000 | 
| LogP | 2.93 | 
| Vapour Pressure | 0.0±1.3 mmHg at 25°C | 
| Index of Refraction | 1.640 | 
| Hazard Codes | Xi | 
|---|